A soft robot could perform real-time imaging, deliver drugs, and take biopsies within the hard-to-reach small intestine.

Measuring cell-free DNA in blood could help oncologists assess how well CAR T-cell therapy is working for treatment of blood ...

A new AI system from Mayo Clinic finds signs of the most common form of pancreatic cancer much earlier than standard ...

Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...

UBT251, the triple hormone-receptor agonist developed by United Biotechnology and licensed by Novo Nordisk for treatment of type 2 diabetes and obesity, has achieved good blood sugar-lowering and ...

A blood test measuring proteins released by the brain after injury could help clinicians identify patients with traumatic brain injury (TBI) who may otherwise go undiagnosed. Published today in the ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, personalized health interactions.

Europe has world-class biotech research, but can it scale? Nordic Life Science Days explores the capital, expertise, and ...

A functional map of more than 13,000 KCNQ1 variants has given researchers better understanding of those involved with long QT syndrome pathogenesis.